Neurokinin (NK) 1 Antagonist
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Neurokinin (NK) 1 Antagonist, covering 2019-04-22 to 2019-04-22. Get the full timeline:
Most recent: Clinical Trial Update: Neurokinin (NK) 1 Antagonist for Pathological Aggression for Harmful, Impulsive, and Self-/Aggressive Behaviour [Phase 1, Phase 2]